![Virginia Kirby](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Virginia Kirby
Director/Board Member at NYXOAH SA
Net worth: 283 986 $ as of 2024-05-30
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Robert Taub | M | 78 | 15 years | |
Olivier Taelman | M | 54 | 5 years | |
Daniel Wildman | M | 68 | 1 years | |
Kevin Rakin | M | 63 | 8 years | |
Robert van Tassel | M | - |
Minneapolis Heart Institute Foundation, Inc.
| - |
Jürgen Hambrecht | M | 77 | 8 years | |
Jeyakumar Subbaroyan | M | - | - | |
Dorit Nahari | M | - | 4 years | |
Rita Johnson-Mills | F | 65 | 3 years | |
Yale T. Dolginow | M | 81 |
Minneapolis Heart Institute Foundation, Inc.
| - |
Inge Vanwittenbergh | F | - | - | |
Kristine Fortman | F | - |
Minneapolis Heart Institute Foundation, Inc.
| - |
Loïc Moreau | M | - | 2 years | |
Bruno Onkelinx | M | - | 3 years | |
Roi Tsukran | M | - | 8 years | |
An Moonen | F | - | 4 years | |
Lori Milbrandt | F | - |
Minneapolis Heart Institute Foundation, Inc.
| - |
Francis Kim | M | - | 1 years | |
Gregory Graves | M | 63 |
Minneapolis Heart Institute Foundation, Inc.
| 8 years |
Wesley R. Pedersen | M | - |
Minneapolis Heart Institute Foundation, Inc.
| - |
Archie Smith | M | 69 |
Minneapolis Heart Institute Foundation, Inc.
| - |
Pierre Gianello | M | 68 | 6 years | |
John Seaberg | M | 72 |
Minneapolis Heart Institute Foundation, Inc.
| - |
David Saggau | M | - |
Minneapolis Heart Institute Foundation, Inc.
| - |
David DeMartino | M | - | - | |
Steven Sjoblad | M | 74 |
Minneapolis Heart Institute Foundation, Inc.
| - |
William Katsiyiannis | M | - |
Minneapolis Heart Institute Foundation, Inc.
| 11 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Charles McKhann | M | 55 |
Apnex Medical, Inc.
![]() Apnex Medical, Inc. Medical SpecialtiesHealth Technology Apnex Medical, Inc. manufactured medical devices. It developed a proprietary active implantable medical device for the treatment of obstructive sleep apnea (OSA). The company was founded by Chad J. Kugler, Michael L. Berman and Robert E. Atkinson in 2006 and was headquartered in St. Paul, MN. | - |
James Corbett | M | 65 |
ev3, Inc.
![]() ev3, Inc. Medical SpecialtiesHealth Technology ev3, Inc. is a provider for specialists treating a range of vascular diseases and disorders. ev3 is committed to the peripheral vascular and neurovascular markets offering a portfolio of treatment options, including interventional technologies used such as plaque excision systems, PTA balloons, stents, embolic protection, thrombectomy, embolization coils, liquid embolics, occlusion balloons and procedural support. | 4 years |
Russell W. Felkey | M | 73 |
EnteroMedics, Inc.
![]() EnteroMedics, Inc. Medical SpecialtiesHealth Technology EnteroMedics, Inc. is a medical device company, which in the design, and development of devices that use neuroblocking technology to treat obesity,metabolic diseases, and other gastrointestinal disorders. It offers vBlock system, which is a therapy to limit expansion of hte stomach, help control hunger sensations between meals, reduce the frequency and intensity of stomach contractions and produce a feeling of early and prolonged fullness. The company was founded by Mark B. Knudson, Robert S. Nickoloff, Timothy R. Conrad, Katherine S. Tweden and Richard R. Wilson on December 19, 2002 and is headquartered in St. Paul, MN. | 3 years |
Adrianus Donders | M | 70 |
EnteroMedics, Inc.
![]() EnteroMedics, Inc. Medical SpecialtiesHealth Technology EnteroMedics, Inc. is a medical device company, which in the design, and development of devices that use neuroblocking technology to treat obesity,metabolic diseases, and other gastrointestinal disorders. It offers vBlock system, which is a therapy to limit expansion of hte stomach, help control hunger sensations between meals, reduce the frequency and intensity of stomach contractions and produce a feeling of early and prolonged fullness. The company was founded by Mark B. Knudson, Robert S. Nickoloff, Timothy R. Conrad, Katherine S. Tweden and Richard R. Wilson on December 19, 2002 and is headquartered in St. Paul, MN. | - |
Donald L. Deyo | M | 65 | 6 years | |
Michael P. Winegar | M | 63 |
ev3, Inc.
![]() ev3, Inc. Medical SpecialtiesHealth Technology ev3, Inc. is a provider for specialists treating a range of vascular diseases and disorders. ev3 is committed to the peripheral vascular and neurovascular markets offering a portfolio of treatment options, including interventional technologies used such as plaque excision systems, PTA balloons, stents, embolic protection, thrombectomy, embolization coils, liquid embolics, occlusion balloons and procedural support. | 4 years |
Raymond Cohen | M | 65 | - | |
Chris Smith | M | 61 |
ev3, Inc.
![]() ev3, Inc. Medical SpecialtiesHealth Technology ev3, Inc. is a provider for specialists treating a range of vascular diseases and disorders. ev3 is committed to the peripheral vascular and neurovascular markets offering a portfolio of treatment options, including interventional technologies used such as plaque excision systems, PTA balloons, stents, embolic protection, thrombectomy, embolization coils, liquid embolics, occlusion balloons and procedural support. | - |
Pascal Girin | M | 64 |
ev3, Inc.
![]() ev3, Inc. Medical SpecialtiesHealth Technology ev3, Inc. is a provider for specialists treating a range of vascular diseases and disorders. ev3 is committed to the peripheral vascular and neurovascular markets offering a portfolio of treatment options, including interventional technologies used such as plaque excision systems, PTA balloons, stents, embolic protection, thrombectomy, embolization coils, liquid embolics, occlusion balloons and procedural support. | 7 years |
Jan Janssen | M | 60 | 4 years | |
Jack D. Stewart | M | - |
ev3, Inc.
![]() ev3, Inc. Medical SpecialtiesHealth Technology ev3, Inc. is a provider for specialists treating a range of vascular diseases and disorders. ev3 is committed to the peripheral vascular and neurovascular markets offering a portfolio of treatment options, including interventional technologies used such as plaque excision systems, PTA balloons, stents, embolic protection, thrombectomy, embolization coils, liquid embolics, occlusion balloons and procedural support. | 2 years |
Scott Kellen | M | 59 |
ev3, Inc.
![]() ev3, Inc. Medical SpecialtiesHealth Technology ev3, Inc. is a provider for specialists treating a range of vascular diseases and disorders. ev3 is committed to the peripheral vascular and neurovascular markets offering a portfolio of treatment options, including interventional technologies used such as plaque excision systems, PTA balloons, stents, embolic protection, thrombectomy, embolization coils, liquid embolics, occlusion balloons and procedural support. | 2 years |
Manuel Lanfossi | M | - |
ev3, Inc.
![]() ev3, Inc. Medical SpecialtiesHealth Technology ev3, Inc. is a provider for specialists treating a range of vascular diseases and disorders. ev3 is committed to the peripheral vascular and neurovascular markets offering a portfolio of treatment options, including interventional technologies used such as plaque excision systems, PTA balloons, stents, embolic protection, thrombectomy, embolization coils, liquid embolics, occlusion balloons and procedural support. | 2 years |
Christopher J. Gostout | M | 73 |
EnteroMedics, Inc.
![]() EnteroMedics, Inc. Medical SpecialtiesHealth Technology EnteroMedics, Inc. is a medical device company, which in the design, and development of devices that use neuroblocking technology to treat obesity,metabolic diseases, and other gastrointestinal disorders. It offers vBlock system, which is a therapy to limit expansion of hte stomach, help control hunger sensations between meals, reduce the frequency and intensity of stomach contractions and produce a feeling of early and prolonged fullness. The company was founded by Mark B. Knudson, Robert S. Nickoloff, Timothy R. Conrad, Katherine S. Tweden and Richard R. Wilson on December 19, 2002 and is headquartered in St. Paul, MN. | 2 years |
Christoph Eigenmann | M | - | 1 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 22 | 52.38% |
Belgium | 20 | 47.62% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Virginia Kirby
- Personal Network